Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
BSEM
HoldUnloved QualityBioStem Technologies, Inc. · Healthcare · United States · $63M · Avg Vol: $516K/d
40
StockRankGet insider-trade alerts
Q
56
V
55
M
22
P/E (TTM)
4.2x
ROE
-74.7%
D/E
0.0x
Dividend %
—
COMPANY DESCRIPTION
BioStem Technologies, Inc. is a biotechnology company focused on the research and development of regenerative medicine products, particularly perinatal tissue-derived therapeutics. The company operates in the specialty niche of non-invasive regenerative solutions, targeting applications in pain management and orthopedics.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.3M | 6.9M | 16.7M | 301.8M | 311.2% | 34.6M | 28.7M | 53.9M | -43.7% |
| EPS | -0.12 | -0.63 | -0.62 | 1.95 | — | 0.88 | — | — | — |
| Shares | — | 12.2M | 16.2M | 16.6M | +36.9% | 17.8M | — | — | — |
| Debt | 4.8M | 5.1M | 4.7M | 4.4M | -3.1% | 1.2M | — | — | — |
| Equity | -6.0M | -4.1M | -1.3M | 40.9M | — | — | — | — | — |
| Op CF | -0.1M | 0.3M | -3.5M | 24.5M | 797.9% | -5.9M | — | — | — |
| Inv CF | -7.8K | -0.5M | -0.2M | -1.7M | — | — | — | — | — |
| Fin CF | 0.4M | 0.6M | 3.2M | -0.2M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+30.1%
SMA 50SMA 200
Close
$4.18
RSI (14)
60.5
52W High
$8.40
From 52W High
0.5%
SCORE BREAKDOWN
Quality
56
ROIC
75.7%99.5
ROE
-74.7%13.1
GP/Assets
19.7%44.1
Op. Margin
-106.3%16.5
FCF/Assets
n/mN/A
Piotroski
783.9
Int. Cover
50.0x89.2
D/E Ratio
0.04x72.6
Current Ratio
0.98x10.4
Value
55
P/E (TTM)
4.2x98.3
EV/EBITDA
-2.7x25.0
P/FCF
n/mN/A
P/B
2.4x55.3
P/S
1.9x70.2
Div Yield
—N/A
Momentum
22
52W High %
50%23.2
RS 6M
-32%28.6
SMA 50/200
0.81x16.9
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
-67%7.7
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$63M
P/E (Forward)
12.8x
Gross Margin
79.9%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BSEM are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BSEM | BioStem Technologies, Inc.(you) | $63M | 40 | Hold |
| BOLD | Boundless Bio, Inc. | $64M | 36 | Hold |
| XLO | Xilio Therapeutics, Inc. | $59M | 36 | Hold |
| INMB | INmune Bio Inc. | $65M | 33 | Sell |
| CSBR | Champions Oncology, Inc. | $68M | 29 | Sell |
| RNXT | RenovoRx, Inc. | $75M | 31 | Sell |
| FBIO | Fortress Biotech, Inc. | $92M | 44 | Hold |
| APLM | Apollomics, Inc. | $77M | 29 | Sell |
| XBIT | XBiotech Inc. | $69M | 27 | Sell |
| MNOV | MediciNova, Inc. | $71M | 24 | Sell |
Peer medians: ROE -30.5% · P/E 27.1x · Gross margin 58.1%